HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2024 PSYCHEDELIC INVESTOR CONFERENCE
Search
PSYCH NEWS
2023 Watch List
2024 WATCH LIST
ALCOHOL
CHARITY
CLIENT
CLINICAL TRIALS
CLINICS
CONFERENCES
DECK
INTERVIEW
INVESTORS
IPO
LARGE CAP PSYCH
NEO
PSYCH FUND | ETF
PSYCH NEWS
PSYCH STOCK NEWS
Psychedelic Investor Guide
Psychedelic Investor TV
RESEARCH
SIDE STORIES
STUFF
SUBSCRIBE
TESTIMONIALS
UNIVERSE
VETS
VIDEOS
Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi...
Editor | Curator
-
April 3, 2024
Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million
Editor | Curator
-
January 30, 2024
Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7....
Editor | Curator
-
January 30, 2024
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
June 4, 2023
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
May 15, 2023
Ketamine and Yale University
May 15, 2023
Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund...
May 9, 2023
PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL...
February 22, 2023
‘Magic Mushroom’ Psychedelic may Help Heavy Drinkers Quit (AP News)
August 25, 2022
Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.
June 22, 2022
Coming This Monday
November 5, 2021
Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.
September 29, 2021
Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
September 27, 2021
1
2
3
Page 2 of 3
